Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiencyAndrea Galassi, Mario Cozzolino, Giulia Boni Brivio et al.|Expert Opinion on Drug Safety|2021Cited by 10
Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary HyperparathyroidismPaola Monciino, Mario Cozzolino, Lorenza Magagnoli et al.|Kidney and Dialysis|2022Cited by 0